geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 - - PowerPoint PPT Presentation
geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 - - PowerPoint PPT Presentation
geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 Hepatitis C Small, enveloped flavivirus (ss+ RNA) 9.6 kb-long genome, 10 proteins Affects hepatocytes in human, chimp ~200 Million infected humans, most
Hepatitis C
2
Hepatitis-C Virus
- Small, enveloped flavivirus (ss+ RNA)
- 9.6 kb-long genome, 10 proteins
- Affects hepatocytes in human, chimp
- ~200 Million infected humans, most
- f them not diagnosed
- Leads to liver cirrhosis, liver cancer
Liver cirrhosis / cancer
Genomic structure of HCV
3
Genomic structure (Lindenbach et al., 2005) Viral genotypes (Simmonds et al., 2005)
- 6 genotypes
- 30 subtypes
Standard of Care
4 SOC Drugs SVR Rates with SOC
New Protease Inhibitors
5 RESPOND-2 (exp, phase III) REALIZE (exp, phase III)
Resistance
6
NS3 resistance mutations (Welsch et al, 2008) Interpretation and decision support (Roomp et al., 2006) Triple combination therapy
Geno2Pheno[hcv]
7
Genotyping: Necessity of STAT-C (side effects) Resistance mutations: Identify resistance mutations known from literature Infer virus susceptibility Free, web-based genotype interpretation system: Provide MDs and virologists with information about an uploaded viral sequence
www.genafor.org
8
Genotyping is based on NS5B
9 Find nearest reference sub-genotype by sequence similarity
NS3: Resistance by drug
10 Summarize known resistance mutations by drug
PDF Output
11
NS3 Alignment is presented
12 Identify known resistance patterns extracted from literature
Outlook
13
New Drugs
(Asselah et al., 2011)
Host genotype information
(Ge al., 2009)
Phenotypic Resistance Data
(Beerenwinkel et al., 2003)
Acknowledgements
14
Sven-Eric Schelhorn Anna Marie Sikorski Michael Zeidler Saleta Sierra-Aragon Georg Friedrich Joachim Büch Rolf Kaiser Thomas Lengauer